Abbott has been awarded the Shingo Prize, an international award for operational excellence, by the Shingo Institute at the Jon M Huntsman School of Business at Utah State University. Abbott’s vascular devices manufacturing facility in Clonmel, Ireland, received the award, recognising the site’s initiative to develop and maintain continuous improvement to achieve operational excellence. The prize is awarded to organisations that demonstrate a culture where principles of operational excellence are deeply embedded into the thinking and behaviour of all leaders, managers and associates.
“Only the highest-performing organizations are considered for the Shingo Prize,” said Robert Miller, Executive Director, Shingo Institute. “Organisations that receive the top Shingo Prize have successfully created a culture characterised by excellence, respect, humility, the quest for perfection and flow of value to the customer. Ultimately, these are some of the best organisations in the world.”
The Shingo Prize, established in 1988, is named after Japanese industrial engineer Shigeo Shingo, who distinguished himself as one of the world’s thought leaders in concepts, management systems and improvement techniques. The Shingo Prize began as a way to recognise and inspire excellence in manufacturing but has grown to serve as the global standard for enterprise excellence. The Shingo Prize is open to organisations across all industries and sectors globally. Abbott’s vascular devices manufacturing facility in Clonmel is the first organisation in Europe to achieve the standards required to receive the top Shingo Prize.
Abbott’s Clonmel facility is a centre of excellence in the manufacturing of medical devices used to treat people with vascular diseases, including heart disease, in more than 100 countries around the world. By adopting the Shingo model of operational excellence and continued improvement, the team at Abbott further developed and strengthened its long-term vision and strategy, discovered the most effective ways to foster collaboration among employees, and identified opportunities to enhance the way the company manufactures medical devices. As a result, the Clonmel site has achieved significant increases in productivity, while maintaining the highest standards of quality as it brings innovative medical technologies to the market.
“Abbott’s dedication to excellence is a driving force across all functions and roles, and is central to our development of innovative business solutions so that we can continue to deliver world-class products to our customers,” said Chuck Foltz, Senior Vice President, vascular, Abbott. “Receiving the top Shingo Prize for our manufacturing facility in Clonmel is a testament to the deep commitment of our employees and to our ongoing focus on serving the people who benefit from our products.”
EP News Bureau – Mumbai
- Advertisement -
